174 related articles for article (PubMed ID: 34918626)
1. Comparative efficacy and safety of antipseudomonal β-lactams for pediatric febrile neutropenia: A systematic review and Bayesian network meta-analysis.
Tan X; Li Y; Xi J; Guo S; Su H; Chen X; Liang X
Medicine (Baltimore); 2021 Dec; 100(50):e27266. PubMed ID: 34918626
[TBL] [Abstract][Full Text] [Related]
2. Anti-pseudomonal beta-lactams for the initial, empirical, treatment of febrile neutropenia: comparison of beta-lactams.
Paul M; Yahav D; Bivas A; Fraser A; Leibovici L
Cochrane Database Syst Rev; 2010 Nov; 2010(11):CD005197. PubMed ID: 21069685
[TBL] [Abstract][Full Text] [Related]
3. Comparison of antipseudomonal β-lactams for febrile neutropenia empiric therapy: systematic review and network meta-analysis.
Horita N; Shibata Y; Watanabe H; Namkoong H; Kaneko T
Clin Microbiol Infect; 2017 Oct; 23(10):723-729. PubMed ID: 28377312
[TBL] [Abstract][Full Text] [Related]
4. Acute kidney injury following the concurrent administration of antipseudomonal β-lactams and vancomycin: a network meta-analysis.
Bellos I; Karageorgiou V; Pergialiotis V; Perrea DN
Clin Microbiol Infect; 2020 Jun; 26(6):696-705. PubMed ID: 32222460
[TBL] [Abstract][Full Text] [Related]
5. Carbapenems versus alternative β-lactams monotherapy or in combination for febrile neutropenia: Systematic review and meta-analysis of randomized controlled trial.
Tang X; Chen L; Li Y; Jiang J; Li X; Liang X
Medicine (Baltimore); 2020 Oct; 99(43):e22725. PubMed ID: 33120768
[TBL] [Abstract][Full Text] [Related]
6. Effectiveness of novel β-lactams for Pseudomonas aeruginosa infection: A systematic review and meta-analysis.
Huang M; Cai F; Liu C; Zheng H; Lin X; Li Y; Wang L; Ruan J
Am J Infect Control; 2024 Jul; 52(7):774-784. PubMed ID: 38428591
[TBL] [Abstract][Full Text] [Related]
7. Meropenem versus piperacillin/tazobactam for febrile neutropenia in pediatric patients: efficacy of piperacillin/tazobactam as a 1-h drip infusion four times a day.
Kobayashi R; Sano H; Matsushima S; Hori D; Yanagi M; Kodama K; Suzuki D; Kobayashi K
Int J Hematol; 2021 Mar; 113(3):430-435. PubMed ID: 33170417
[TBL] [Abstract][Full Text] [Related]
8. Meropenem versus piperacillin-tazobactam as empiric therapy for febrile neutropenia in pediatric oncology patients.
Sezgin G; Acipayam C; Ozkan A; Bayram I; Tanyeli A
Asian Pac J Cancer Prev; 2014; 15(11):4549-53. PubMed ID: 24969883
[TBL] [Abstract][Full Text] [Related]
9. Activity of Ceftolozane-Tazobactam against Pseudomonas aeruginosa and Enterobacteriaceae Isolates Collected from Respiratory Tract Specimens of Hospitalized Patients in the United States during 2013 to 2015.
Castanheira M; Duncan LR; Mendes RE; Sader HS; Shortridge D
Antimicrob Agents Chemother; 2018 Mar; 62(3):. PubMed ID: 29263073
[TBL] [Abstract][Full Text] [Related]
10. A Randomized, Open-Labeled, Prospective Controlled Study to Assess the Efficacy of Frontline Empirical Intravenous Piperacillin/Tazobactam Monotherapy in Comparison with Ceftazidime Plus Amikacin for Febrile Neutropenia in Pediatric Oncology Patients.
Kamonrattana R; Sathitsamitphong L; Choeyprasert W; Charoenkwan P; Natesirinilkul R; Fanhchaksai K
Asian Pac J Cancer Prev; 2019 Sep; 20(9):2733-2737. PubMed ID: 31554370
[TBL] [Abstract][Full Text] [Related]
11. Carbapenems versus other beta-lactams in the treatment of hospitalised patients with infection: a mixed treatment comparison.
Edwards SJ; Clarke MJ; Wordsworth S; Welton NJ
Curr Med Res Opin; 2009 Jan; 25(1):251-61. PubMed ID: 19210156
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of extended infusion of β-lactam antibiotics for the treatment of febrile neutropenia in haematologic patients: protocol for a randomised, multicentre, open-label, superiority clinical trial (BEATLE).
Laporte-Amargos J; Gudiol C; Arnan M; Puerta-Alcalde P; Carmona-Torre F; Huguet M; Albasanz-Puig A; Parody R; Garcia-Vidal C; Del Pozo JL; Batlle M; Tebé C; Rigo-Bonnin R; Muñoz C; Padullés A; Tubau F; Videla S; Sureda A; Carratalà J
Trials; 2020 May; 21(1):412. PubMed ID: 32423462
[TBL] [Abstract][Full Text] [Related]
13. Ceftriaxone versus beta-lactams with antipseudomonal activity for empirical, combined antibiotic therapy in febrile neutropenia: a meta-analysis.
Furno P; Dionisi MS; Bucaneve G; Menichetti F; Del Favero A
Support Care Cancer; 2000 Jul; 8(4):293-301. PubMed ID: 10923769
[TBL] [Abstract][Full Text] [Related]
14.
Goodlet KJ; Nicolau DP; Nailor MD
Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28923865
[TBL] [Abstract][Full Text] [Related]
15. Ertapenem versus piperacillin/tazobactam for the treatment of complicated infections: a meta-analysis of randomized controlled trials.
An MM; Zou Z; Shen H; Zhang JD; Chen ML; Liu P; Wang R; Jiang YY
BMC Infect Dis; 2009 Dec; 9():193. PubMed ID: 19951447
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of cefoperazone-sulbactam in empiric therapy for febrile neutropenia: A systemic review and meta-analysis.
Lan SH; Chang SP; Lai CC; Lu LC; Tang HJ
Medicine (Baltimore); 2020 Feb; 99(8):e19321. PubMed ID: 32080150
[TBL] [Abstract][Full Text] [Related]
17. Clinical cure rate and cost-effectiveness of carbapenem-sparing beta-lactams vs. meropenem for Gram-negative infections: A systematic review, meta-analysis, and cost-effectiveness analysis.
Nguyen CP; Dan Do TN; Bruggemann R; Ten Oever J; Kolwijck E; Adang EMM; Wertheim HFL
Int J Antimicrob Agents; 2019 Dec; 54(6):790-797. PubMed ID: 31284041
[TBL] [Abstract][Full Text] [Related]
18. Empirical antibiotic monotherapy for febrile neutropenia: systematic review and meta-analysis of randomized controlled trials.
Paul M; Yahav D; Fraser A; Leibovici L
J Antimicrob Chemother; 2006 Feb; 57(2):176-89. PubMed ID: 16344285
[TBL] [Abstract][Full Text] [Related]
19. [Piperacillin/tazobactam plus amikacin vs. piperacilin/tazobactam: treatment for children with febrile neutropenia].
Pacheco-Rosas DO; Peregrino-Bejarano L; López-Aguilar JE; Juan-Shum L; Miranda-Novales MG
Rev Med Inst Mex Seguro Soc; 2019 Jul; 57(2):65-73. PubMed ID: 31617992
[TBL] [Abstract][Full Text] [Related]
20. Ceftazidime, Carbapenems, or Piperacillin-tazobactam as Single Definitive Therapy for Pseudomonas aeruginosa Bloodstream Infection: A Multisite Retrospective Study.
Babich T; Naucler P; Valik JK; Giske CG; Benito N; Cardona R; Rivera A; Pulcini C; Abdel Fattah M; Haquin J; Macgowan A; Grier S; Gibbs J; Chazan B; Yanovskay A; Ben Ami R; Landes M; Nesher L; Zaidman-Shimshovitz A; McCarthy K; Paterson DL; Tacconelli E; Buhl M; Mauer S; Rodriguez-Bano J; Morales I; Oliver A; Ruiz De Gopegui E; Cano A; Machuca I; Gozalo-Marguello M; Martinez Martinez L; Gonzalez-Barbera EM; Alfaro IG; Salavert M; Beovic B; Saje A; Mueller-Premru M; Pagani L; Vitrat V; Kofteridis D; Zacharioudaki M; Maraki S; Weissman Y; Paul M; Dickstein Y; Leibovici L; Yahav D
Clin Infect Dis; 2020 May; 70(11):2270-2280. PubMed ID: 31323088
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
